The global pharmaceutical landscape is undergoing a profound structural evolution, driven by surging demand for treatments addressing obesity, type 2…
Read More
WuXi XDC and Ona Therapeutics Expand Partnership Through Exclusive Global Licensing Agreement for Advanced Antibody-Drug Conjugate Platform
In a significant expansion of their ongoing strategic partnership, WuXi XDC Cayman has entered into an exclusive global licensing agreement…
Read More
Exegenesis Bio and Modalis Therapeutics Join Forces in Strategic Licensing Agreement to Advance MDL-201 Gene Therapy for Duchenne Muscular Dystrophy
In a significant development for the field of genetic medicine, biotechnology innovators Exegenesis Bio and Modalis Therapeutics have formally announced…
Read More
AviadoBio Expands Exclusive Licensing of vMiX Gene-Silencing Platform to Encompass All Human Therapeutic Areas
AviadoBio has significantly broadened its strategic horizons through an expanded exclusive licensing agreement with King’s College London. This pivotal development…
Read More
ACROBiosystems Enhances Global Licensing for HEK293 Functional Cell Lines to Accelerate Biopharmaceutical R&D
ACROBiosystems has announced a significant upgrade to its global licensing solution for HEK293 functional cell lines, a move poised to…
Read MoreYOU MAY HAVE MISSED
